Two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for treating locally advanced esophageal cancer: short-term outcomes of a multicenter randomized phase II trial
Osamu Shiraishi(Kindai University), Takushi Yasuda(Osaka International Cancer Institute), Masahiko Yano(Nagoya Sangyo University), Masaaki Motoori(Osaka International Cancer Institute), Hiroshi Miyata(Osaka University), Yuichiro� Doki(Osaka Gakuin University), Makoto Yamasaki(The University of Osaka), Koji Tanaka(Mie University), Taroh Satoh(Osaka University Hospital), Kazumasa Fujitani(Osaka Prefectural Medical Center), Tomoki Makino(The University of Osaka), Yutaka Kimura(Kansai Medical University), Motohiro Hirao(Osaka National Hospital), Keijiro Sugimura(Osaka International Cancer Institute), Kotaro Yamashita(The University of Osaka), Tomo Ishida(The University of Osaka), Atsushi Takeno(Kansai Rosai Hospital)
Cited by 24
Related Papers
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Genome-wide Expression Analysis of Mouse Liver Reveals CLOCK-regulated Circadian Output Genes
|Journal of Biological Chemistry|2003|347
A novel image‐guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation
|Journal of Surgical Oncology|2009|333
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324